Living-Donor Lobar Lung Transplantation for Pulmonary and Abdominopelvic Lymphangioleiomyomatosis

Abstract

We performed emergency living-donor lobar lung transplantation (LLTx) successfully in a 24-year-old woman with end-stage pulmonary and massive abdominopelvic lymphangioleiomyomatosis (LAM). Preoperatively, her respiratory condition was critical, but abdominopelvic lesions had been well controlled with medication. No LAM patients with massive abdominopelvic lesions as in the present case have been reportedly treated by LLTx previously. The present case demonstrates that LLTx can be a therapeutic option for end-stage pulmonary LAM with massive abdominopelvic involvement.

Key words

Pulmonary lymphangioleiomyomatosis - abdominopelvic lymphangioleiomyomatosis - lung transplantation

References

• 1 Starnes V A, Barr M L, Cohen R G. Lobar transplantation. Indications, technique, and outcome.  J Thorac Cardiovasc Surg. 1994;  108 403-411
• 2 Omasa M, Hasegawa S, Bando T. et al . Application of ET-Kyoto solution in clinical lung transplantation.  Ann Thorac Surg. 2004;  77 338-339
• 3 Collins J, Müller N L, Kazerooni E A. et al . Lung transplantation for lymphangioleiomyomatosis: Role of imaging in the assessment of complications related to the underlying disease.  Radiology. 1999;  210 325-332
• 4 Avila N A, Kelly J A, Chu S C. et al . Lymphangioleiomyomatosis: abdominopelvic CT and US findings.  Radiology. 2000;  216 147-153
• 5 Boehle A, Speich R, Russi E W. et al . Lung transplantation for lymphangioleiomyomatosis.  N Eng J Med. 1996;  335 1275-1280